Sign in

NCT02741349Recruiting

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

Impact of Clinical, Echocardiographic and Biological Parameters to the Risk of Cardiovascular Disease in Patients With Non-valvular Atrial Fibrillation.

Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of the present prospective study is to further develop and validate a composite risk score predicting both ischemic and bleeding risk, based on epidemiologic, clinical, biological, and/or morphologic complementary data. First, the investigators will assess the predictive performance of current clinical risk scores. Second, the investigators will assess the potential predictive value of additional markers. Third, the investigators will aim to develop a new risk score.

Status (registry)
Recruiting
Study type
Observational
Enrollment
825 (estimated)
First submitted
7 Apr 2016
Start date
27 Jul 2015
Primary completion date
Dec 2025
Lead sponsor
Saint Antoine University Hospital
NCT number
NCT02741349

What you commit to

  • Study type: Observational
  • Planned participants: 825
  • From 27 Jul 2015 to the primary completion date, Dec 2025
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients presenting a clinically and echocardiographically significant valve disease defined as :
    • mitral stenosis with a valve area \< 2cm2
    • mitral insufficiency (grade 3 or 4)
    • aortic insufficiency (grade 3 or 4)
    • tricuspid insufficiency (grade 3 or 4)
    • aortic stenosis with a valve area \< 1.5 cm2
    • mechanical valve prosthèses
  • Secondary AF due to an acute cause (thyrotoxicosis, acute pericarditis, infection, systemic disease)
  • Severe psychiatric history

Other

  • Presence of a contraindication to long term anticoagulant treatment
  • Absence of social security coverage
  • Impossibility of follow-up

Who the study is looking for

  • Adults above 18 years of age
  • Presenting a NVAF which is paroxysmal, persistent or permanent and documented by an electrocardiogram (ECG)
  • Willing and able to give written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Service de cadiologie - Hôpital Pitié Salpêtrière
Coordinator of this site? Confirm its status
ParisFranceSuspended
Service de cardiologie - hôpital Saint Antoine
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Centre Cardiologique du Nord
Coordinator of this site? Confirm its status
Saint-DenisFranceRecruiting
Service de cardiologie - Clinique Pasteur
Coordinator of this site? Confirm its status
ToulouseFranceSuspended

This page is information, not medical advice. Discuss any trial with your doctor.